Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Psychiatry Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Psychiatry Other
    Risperidone With Standard Therapy Reduces Relapses of Bipolar Episode Regardless of Episode Type: Presented at CINP - (DGDispatch)
    Aripiprazole Safe for Schizophrenia or Bipolar 1 Disorder in Adolescents: Presented at CINP¶ - (DGDispatch)
    New Criterion May Improve Identification of Dementia Risk in Highly Educated Older Adults - (DGNews)
    FDA Requests Boxed Warnings on Conventional Antipsychotic Drugs - (DGNews)
    Pramlintide-Related Improvements in Diabetes Benefit Patients' Psyche: Presented at ADA - (DGDispatch)

    News archive

     Recent webcasts/CME - Psychiatry Other
    • Dementia in Hispanic Americans: The Reasons Behind the Risk
    • Prevalence and Associated Factors for Suicidal Ideation and Behaviors in Obsessive-Compulsive Disorder
      Delirium Update
      The Pharmacist's Role in Breaking the Cycle of PMDD
      Understanding Autism: The Role of the Pharmacist in the Management of Autism

      Webcasts/CME archive

       Recent cases - Psychiatry Other
        Factitious Lymphoedema as a Psychiatric Condition Mimicking Reflex Sympathetic Dystrophy: A Case Report
        Topiramate-Induced Psychosis in Two Members of the One Family: A Case Report
        Childhood Autism in a 13 Year Old Boy with Oculocutaneous Albinism: A Case Report
        Unexpected Depletion in Plasma Choline and Phosphatidylcholine Concentrations in a Pregnant Woman with Bipolar Affective Disorder Being Treated with Lithuim, Haloperidol and Benztropine: A Case Report
        Recognizing Thyrotoxicosis in a Patient with Bipolar Mania: A Case Report

        Cases archive
          




        my personal edition > psychiatry other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Divalproex Sodium Shows Promise for Reducing Aggression in Bipolar Offspring: Presented at AACAP

        By Jerry Ingram

        MIAMI BEACH, FL -- October 19, 2003 -- Divalproex Sodium (DVPX) appears to offer some help in decreasing aggressive behavior in bipolar offspring, according to a preliminary study presented here on October 17th at the 50th Anniversary Meeting of the American Academy of Child and Adolescent Psychiatry.

        "For clinicians it's an important question of how to address and manage aggression in these children. More times than not, medications are used for that. What we want to do is systematically address first of all the issue of the aggressive behavior and then, more systematically, which medication could be appropriately used. We want to optimally use the medications -- not have children on several different medications. That's where we're going with this," said Kirti Saxena, MD, lead researcher, Stanford University School of Medicine, Stanford, California.

        For this study of the effects of divalproex sodium, investigators conducted a 12-week open label trial, which included 24 bipolar offspring ranging in age from 6 to 18 years. The youngsters had mixed diagnoses of major depression, cyclothymia, attention-deficit/hyperactivity disorder and oppositional defiant disorder. To assess aggression, researchers used the Overt Aggression Scale (OAS) in 4-week intervals.

        They found that 71% of the children who were evaluated were considered "responders to divalproex treatment". Mean OAS scores decreased in the 12-week period (P=0.005) along with verbal aggression (P=0.0039), assault (P=0.001), irritability (P=0.008) and overall aggression (P=0.006). There was a significant correlation between the Young Mania Rating Scale and OAS scores at Week 0 (P=0.036) and Week 12 (P=0.025), researchers stated.

        Although Dr. Saxena concluded that the bipolar offspring did experience a decrease in aggression following treatment with divalproex, she pointed out that this is only an initial finding and the first report of treatment efficacy of a mood stabilizer for aggression in this particular cohort.


        [Study title: Divalproex Sodium Reduces Aggression in Bipolar Offspring with Psychopathology. Abstract D30]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send